Spleen News and Research

RSS
Incyte’s ruxolitinib COMFORT-II Phase III trial in MF meets primary endpoint

Incyte’s ruxolitinib COMFORT-II Phase III trial in MF meets primary endpoint

Study provides insight into why older adults are so vulnerable to pneumonia

Study provides insight into why older adults are so vulnerable to pneumonia

Study provides insight into aging immune system

Study provides insight into aging immune system

Salmonella may serve as valuable tool to fight against cancer

Salmonella may serve as valuable tool to fight against cancer

Protalix: New data from taliglucerase alfa, oral GCD trials to be presented at Lysosomal Disease Network Symposium

Protalix: New data from taliglucerase alfa, oral GCD trials to be presented at Lysosomal Disease Network Symposium

Genzyme reports 3-year follow-up data from eliglustat tartrate Phase 2 trial for Gaucher disease

Genzyme reports 3-year follow-up data from eliglustat tartrate Phase 2 trial for Gaucher disease

Athersys' MultiStem cell therapy provides multiple benefits in preclinical models of ischemic stroke

Athersys' MultiStem cell therapy provides multiple benefits in preclinical models of ischemic stroke

Viral infection of Leishmania leads to increased pathogenicity

Viral infection of Leishmania leads to increased pathogenicity

Dream Foundation to fulfill final dream for Stage III Pancreatic Cancer patient

Dream Foundation to fulfill final dream for Stage III Pancreatic Cancer patient

Phase II trial finds fostamatinib ineffective in RA patients not responsive to biologic agents

Phase II trial finds fostamatinib ineffective in RA patients not responsive to biologic agents

Researchers find food-borne bacteria can cause difficult-to-treat heart infections

Researchers find food-borne bacteria can cause difficult-to-treat heart infections

Scientists create particles that resemble RBC, pave way for development of synthetic blood

Scientists create particles that resemble RBC, pave way for development of synthetic blood

Insecticidal nets do not always work against diseases transmitted by insect bites

Insecticidal nets do not always work against diseases transmitted by insect bites

Low levels of microbe-killing molecules improve survival rate of people with CGD

Low levels of microbe-killing molecules improve survival rate of people with CGD

Positive results from Incyte's COMFORT-I INCB18424 pivotal Phase III clinical trial in myelofibrosis

Positive results from Incyte's COMFORT-I INCB18424 pivotal Phase III clinical trial in myelofibrosis

Clinical, preclinical results of ISF35 in CLL patients presented at ASH 2010

Clinical, preclinical results of ISF35 in CLL patients presented at ASH 2010

p53 activation offers a novel strategy for cancer therapy

p53 activation offers a novel strategy for cancer therapy

Mayo Clinic scientists say JAK inhibitors may help treat patients with myelofibrosis

Mayo Clinic scientists say JAK inhibitors may help treat patients with myelofibrosis

Positive interim data from Phase I/II trial of CYT387 in myelofibrosis presented at ASH Annual Meeting

Positive interim data from Phase I/II trial of CYT387 in myelofibrosis presented at ASH Annual Meeting

Preclinical study results for Syk, JAK inhibitor program presented at ASH 2010

Preclinical study results for Syk, JAK inhibitor program presented at ASH 2010

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.